Copyright Reports & Markets. All rights reserved.

Global and United States Dengue Rapid Test Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Dengue Rapid Test Revenue in Dengue Rapid Test Business (2017-2022) & (US$ Million) Introduction
    • 1.2 Global Dengue Rapid Test Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Dengue Rapid Test Market Size for the Year 2017-2028
      • 1.2.2 Global Dengue Rapid Test Market Size for the Year 2017-2028
    • 1.3 Dengue Rapid Test Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.3.1 The Market Share of United States Dengue Rapid Test in Global, 2017 VS 2022 VS 2028
      • 1.3.2 The Growth Rate of Dengue Rapid Test Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.4 Dengue Rapid Test Market Dynamics
      • 1.4.1 Dengue Rapid Test Industry Trends
      • 1.4.2 Dengue Rapid Test Market Drivers
      • 1.4.3 Dengue Rapid Test Market Challenges
      • 1.4.4 Dengue Rapid Test Market Restraints
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Dengue Rapid Test by Type

    • 2.1 Dengue Rapid Test Market Segment by Type
      • 2.1.1 ELISA-Based Test
      • 2.1.2 NS1-Rapid Dengue Test
      • 2.1.3 RT-PCR Amplification Test
      • 2.1.4 Dengue IgG/IgM Rapid Test
      • 2.1.5 Others
    • 2.2 Global Dengue Rapid Test Market Size by Type (2017, 2022 & 2028)
    • 2.3 Global Dengue Rapid Test Market Size by Type (2017-2028)
    • 2.4 United States Dengue Rapid Test Market Size by Type (2017, 2022 & 2028)
    • 2.5 United States Dengue Rapid Test Market Size by Type (2017-2028)

    3 Dengue Rapid Test by Application

    • 3.1 Dengue Rapid Test Market Segment by Application
      • 3.1.1 Medical Hospitals
      • 3.1.2 Diagnostic Centers
      • 3.1.3 Others
    • 3.2 Global Dengue Rapid Test Market Size by Application (2017, 2022 & 2028)
    • 3.3 Global Dengue Rapid Test Market Size by Application (2017-2028)
    • 3.4 United States Dengue Rapid Test Market Size by Application (2017, 2022 & 2028)
    • 3.5 United States Dengue Rapid Test Market Size by Application (2017-2028)

    4 Global Dengue Rapid Test Competitor Landscape by Company

    • 4.1 Global Dengue Rapid Test Market Size by Company
      • 4.1.1 Top Global Dengue Rapid Test Companies Ranked by Revenue (2021)
      • 4.1.2 Global Dengue Rapid Test Revenue by Player (2017-2022)
    • 4.2 Global Dengue Rapid Test Concentration Ratio (CR)
      • 4.2.1 Dengue Rapid Test Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Companies of Dengue Rapid Test in 2021
      • 4.2.3 Global Dengue Rapid Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Dengue Rapid Test Headquarters, Revenue in Dengue Rapid Test Business (2017-2022) & (US$ Million) Type
      • 4.3.1 Global Dengue Rapid Test Headquarters and Area Served
      • 4.3.2 Global Dengue Rapid Test Companies Revenue in Dengue Rapid Test Business (2017-2022) & (US$ Million) Type
      • 4.3.3 Date of International Companies Enter into Dengue Rapid Test Market
    • 4.4 Companies Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Dengue Rapid Test Market Size by Company
      • 4.5.1 Top Dengue Rapid Test Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Dengue Rapid Test Revenue by Players (2020, 2021 & 2022)

    5 Global Dengue Rapid Test Market Size by Region

    • 5.1 Global Dengue Rapid Test Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Dengue Rapid Test Market Size by Region (2017-2028)
      • 5.2.1 Global Dengue Rapid Test Market Size by Region: 2017-2022
      • 5.2.2 Global Dengue Rapid Test Market Size by Region (2023-2028)

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Dengue Rapid Test Market Size YoY Growth 2017-2028
      • 6.1.2 North America Dengue Rapid Test Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Dengue Rapid Test Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Dengue Rapid Test Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Dengue Rapid Test Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Dengue Rapid Test Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Dengue Rapid Test Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Dengue Rapid Test Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Dengue Rapid Test Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Dengue Rapid Test Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Maternova
      • 7.1.1 Maternova Company Details
      • 7.1.2 Maternova Business Overview
      • 7.1.3 Maternova Dengue Rapid Test Introduction
      • 7.1.4 Maternova Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.1.5 Maternova Recent Development
    • 7.2 Abbott Laboratories
      • 7.2.1 Abbott Laboratories Company Details
      • 7.2.2 Abbott Laboratories Business Overview
      • 7.2.3 Abbott Laboratories Dengue Rapid Test Introduction
      • 7.2.4 Abbott Laboratories Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.2.5 Abbott Laboratories Recent Development
    • 7.3 OriGene Technologies
      • 7.3.1 OriGene Technologies Company Details
      • 7.3.2 OriGene Technologies Business Overview
      • 7.3.3 OriGene Technologies Dengue Rapid Test Introduction
      • 7.3.4 OriGene Technologies Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.3.5 OriGene Technologies Recent Development
    • 7.4 Euroimmun AG
      • 7.4.1 Euroimmun AG Company Details
      • 7.4.2 Euroimmun AG Business Overview
      • 7.4.3 Euroimmun AG Dengue Rapid Test Introduction
      • 7.4.4 Euroimmun AG Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.4.5 Euroimmun AG Recent Development
    • 7.5 InBios International
      • 7.5.1 InBios International Company Details
      • 7.5.2 InBios International Business Overview
      • 7.5.3 InBios International Dengue Rapid Test Introduction
      • 7.5.4 InBios International Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.5.5 InBios International Recent Development
    • 7.6 NovaTec Immundiagnostica GmbH
      • 7.6.1 NovaTec Immundiagnostica GmbH Company Details
      • 7.6.2 NovaTec Immundiagnostica GmbH Business Overview
      • 7.6.3 NovaTec Immundiagnostica GmbH Dengue Rapid Test Introduction
      • 7.6.4 NovaTec Immundiagnostica GmbH Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.6.5 NovaTec Immundiagnostica GmbH Recent Development
    • 7.7 Abnova Corporation
      • 7.7.1 Abnova Corporation Company Details
      • 7.7.2 Abnova Corporation Business Overview
      • 7.7.3 Abnova Corporation Dengue Rapid Test Introduction
      • 7.7.4 Abnova Corporation Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.7.5 Abnova Corporation Recent Development
    • 7.8 Quest Diagnostics
      • 7.8.1 Quest Diagnostics Company Details
      • 7.8.2 Quest Diagnostics Business Overview
      • 7.8.3 Quest Diagnostics Dengue Rapid Test Introduction
      • 7.8.4 Quest Diagnostics Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.8.5 Quest Diagnostics Recent Development
    • 7.9 DiaSorin Group
      • 7.9.1 DiaSorin Group Company Details
      • 7.9.2 DiaSorin Group Business Overview
      • 7.9.3 DiaSorin Group Dengue Rapid Test Introduction
      • 7.9.4 DiaSorin Group Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.9.5 DiaSorin Group Recent Development
    • 7.10 Roche Molecular Systems
      • 7.10.1 Roche Molecular Systems Company Details
      • 7.10.2 Roche Molecular Systems Business Overview
      • 7.10.3 Roche Molecular Systems Dengue Rapid Test Introduction
      • 7.10.4 Roche Molecular Systems Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.10.5 Roche Molecular Systems Recent Development
    • 7.11 Certest Biotec S.L.
      • 7.11.1 Certest Biotec S.L. Company Details
      • 7.11.2 Certest Biotec S.L. Business Overview
      • 7.11.3 Certest Biotec S.L. Dengue Rapid Test Introduction
      • 7.11.4 Certest Biotec S.L. Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.11.5 Certest Biotec S.L. Recent Development
    • 7.12 Thermo Fisher Scientific
      • 7.12.1 Thermo Fisher Scientific Company Details
      • 7.12.2 Thermo Fisher Scientific Business Overview
      • 7.12.3 Thermo Fisher Scientific Dengue Rapid Test Introduction
      • 7.12.4 Thermo Fisher Scientific Revenue in Dengue Rapid Test Business (2017-2022)
      • 7.12.5 Thermo Fisher Scientific Recent Development

    8 Research Findings and Conclusion

      9 Appendix

      • 9.1 Research Methodology
        • 9.1.1 Methodology/Research Approach
        • 9.1.2 Data Source
      • 9.2 Author Details

      Summary:
      Market Analysis and Insights: Global and United States Dengue Rapid Test Market
      This report focuses on global and United States Dengue Rapid Test market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Dengue Rapid Test market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, ELISA-Based Test accounting for % of the Dengue Rapid Test global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Medical Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Dengue Rapid Test market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
      Global Dengue Rapid Test Scope and Market Size
      Dengue Rapid Test market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Dengue Rapid Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Dengue Rapid Test market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Dengue Rapid Test market is segmented into
      ELISA-Based Test
      NS1-Rapid Dengue Test
      RT-PCR Amplification Test
      Dengue IgG/IgM Rapid Test
      Others
      Segment by Application, the Dengue Rapid Test market is segmented into
      Medical Hospitals
      Diagnostic Centers
      Others
      Regional and Country-level Analysis
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Dengue Rapid Test Market Share Analysis
      Dengue Rapid Test market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Dengue Rapid Test business, the date to enter into the Dengue Rapid Test market, Revenue in Dengue Rapid Test Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
      The major vendors covered:
      Maternova
      Abbott Laboratories
      OriGene Technologies
      Euroimmun AG
      InBios International
      NovaTec Immundiagnostica GmbH
      Abnova Corporation
      Quest Diagnostics
      DiaSorin Group
      Roche Molecular Systems
      Certest Biotec S.L.
      Thermo Fisher Scientific

      Buy now